ArriVent BioPharma — Returns

$Open the interactive terminal to run `audit returns` with custom options.→

Capital Flow Returns Earning Quality Debt Discipline Moat

Key Metrics

US.AVBP · YoY: 2026 Q1 vs 2025 Q1

Metric	Value	YoY
ROE	-13.4%	↑

Unlock Full Report

Sign up or upgrade to view the complete audit analysis.